
zzso treatment decision-making is a highly complex enterprise zzso multiple patient, zzso treatment, and professional factors with the available medical zzso This management complexity can be exacerbated by the interplay of patient age and zzso zzso conditions that can affect patient quality of life, treatment zzso and survival zzso Given the expected increase in median age (and associated zzso zzso of Western populations over the next few decades, the use of evidence-based therapies that appropriately balance treatment intensity and zzso to achieve the desired goal of treatment zzso zzso zzso or zzso will be increasingly important to health care systems, providers, and zzso In this review, we highlight the evidence related to age and zzso as it relates to zzso and chemotherapy decision zzso We will address evidence as it relates to age and zzso considerations separately and also the interplay between the zzso Clinical considerations to adapt radiation and/or chemotherapy treatment to deal with zzso challenges will be zzso zzso gaps, future research, and clinical recommendation in this increasingly important field are highlighted as zzso 

